Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma

Journal of Immunology

Volumn 165, Issue 12, 2000, Pages 7253-7261

  Rimoldi, D ^a   Rubio Godoy, V ^a   Dutoit, V ^a   Lienard, D ^a   Salvi, S ^a   Guillaume, P ^a   Speiser, D ^a   Stockert, E ^a   Spagnoli, G ^a   Servis, C ^a   Cerottini, J C ^a   Lejeune, F ^a   Romero, P ^a   Valmori, D ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GENE PRODUCT; HLA A2 ANTIGEN; PROTEIN NY ESO 1; PROTIN LAGE1; TETRAMER; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ARTICLE; CELL SELECTION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENETIC CODE; HUMAN; HUMAN CELL; LYMPH NODE CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; TUMOR CELL;

EID: 0034671802     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.12.7253     Document Type: Article

References (27)

1. Non-traditionally derived CTL epitopes exceptions that prove the rules?
2. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen
3. A breast and melanoma-shared tumor antigen T cell responses to antigenic peptides translated from different open reading frames
4. Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1
5. A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ
6. Somatic mutations of the APC gene in colorectal tumors mutation cluster region in the APC gene
7. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
8. LAGE-1, a new gene with tumor specificity
9. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1 definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes
10. + T cell response to the cancer testis antigen NY-ESO-1 in melanoma patients
11. Expression of MAGE genes in primary and metastatic cutaneous melanoma
12. Phenotypic analysis of antigen-specific T lymphocytes
13. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes
14. An antigen-targeted approach to adoptive transfer therapy of cancer
15. Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide
16. Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3
17. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes
18. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill
19. Monoclonal antibodies against recombinant-MAGE-1 protein identify a crossreacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells
20. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens
21. NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens
22. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers
23. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure
24. Monitoring CD8 T cell responses to NY-ESO-1 correlation of humoral and cellular immune responses
25. Transfection of IL-2 augments CTL response to human melanoma cells in vitro, immunological characterization of a melanoma vaccine
26. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames
27. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes